Article
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Pediatric diabetes - 1 Jun 2008
Bremer Andrew A, Ranadive Sayali, Lustig Robert H
Abstract excerpt
Neonatal diabetes mellitus is rare, may either be transient or permanent, and may be caused by mutations in any of the several different genes. Until recently, most forms of permanent neonatal diabetes required lifelong subcutaneous insulin for management; however, permanent neonatal diabetes due to activating mutations in the KCNJ11 gene, which encodes the Kir6.2 protein subunit of the ATP-sensitive K+ (K(ATP))...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
